Ireena Vittal joins Cipla executive board
November 29, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cipla, appointment
Indian drug maker Cipla has expanded its board with the addition of Ireena Vittal as an independent director, effective 1 …
PrimeVigilance and PharmInvent combine to create leading, international full service pharmacovigilance, medical information and regulatory service provider
November 29, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
PrimeVigilance and PharmInvent are pleased to announce that they are now working together as an integrated service provider following the …
UK oral cancer rates soar 68% over two decades
November 29, 2016Manufacturing and Production, Medical Communications, Research and Development Cancer Research UK, Oral cancer, mouth cancer
As a move to raise awareness during Mouth Cancer Action Month, Cancer Research UK (CRUK) has released figures of an …
Personalised medicine to drive global lung cancer market to 2020
November 29, 2016Manufacturing and Production, Sales and Marketing Technavio, lung cancer, non-small cell lung cancer
According to a new report from Technavio, the global lung cancer therapeutics market is projected to grow at more than …
Wockhardt UK sterile site hit with FDA warning
November 29, 2016Manufacturing and Production FDA, Wockhardt, Wrexham
Mumbai-based pharmaceutical and biotechnology firm Wockhardt has been hit with more manufacturing woes as the FDA issued a warning letter …
FDA orphan drug designation doubles PhaseRx shares
November 28, 2016Manufacturing and Production, Research and Development, Sales and Marketing FDA, Orphan Drug Designation, PhaseRx
PhaseRx is celebrating as its lead drug candidate PRX-OTC has been orphan drug designation by the US FDA for the …
Biosimilars and Generics: A no-brainer for treatment?
November 28, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biosimilars, generics
The industry is poised on the potential widespread adoption of many revolutionary technologies; foremost among them are biosimilars and generics, …
Patheon acquires state-of-the-art manufacturing facility from Roche
November 28, 2016Manufacturing and Production Patheon, Roche, South Carolina
Patheon, a provider of drug development and delivery to the pharmaceutical and biopharma sectors, announced that it has acquired a …
Teva to market world’s first medical marijuana inhaler
November 28, 2016Research and Development, Sales and Marketing
Israel’s Teva Pharmaceutical Industries has signed an agreement with Tel Aviv-based biotech Syqe Medical for the distribution and marketing of …
Chinese investors push Kymab backing to $100 million
November 28, 2016Sales and Marketing Bill & Melina Gates Foundation, China, kymab
Kymab, the UK-based antibody biopharmaceutical group, announced that it has secured $100 million in funding. The company raised the funds …
Pfizer scraps €400m Dublin facility expansion
November 28, 2016Manufacturing and Production, Sales and Marketing Pfizer, bococizumab
Pfizer has U-turned on its intention to bolster operations at its Grange Castle, Dublin facility in a 34,500 square-metre expansion …
Takeda gains marketing authorisation for multiple myeloma pill
November 28, 2016Sales and Marketing Takeda, multiple myeloma
Takeda Pharmaceutical has announced that they have received conditional marketing authorisation for Ninlaro (ixazomib) for treatment of adult patients with …
GSK applies for EU approval for shingles vaccine
November 28, 2016Sales and Marketing European Commission, GSK, GlaxoSmithKline, Shingrix, shingles
After filing for FDA approval in October, GlaxoSmithKline has now applied for approval from the European Commission (EC) for its …
Taro announces appointment of new CEO
November 25, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Taro pharmaceutical, sun pharmaceutical
Taro Pharmaceutical announced that Uday Baldota will take up the position of CEO and will begin the role in early …
J&J reportedly poised to acquire Europe’s biggest biotech
November 25, 2016Sales and Marketing Actelion, J&J, JJ, Johnson and Johnson, acquisition
Johnson & Johnson could be eyeing a takeover of Swiss biotech Actelion, Europe’s biggest biotech, according to insiders, Bloomberg has …
GSK reaches endgame of race to develop anaemia drug
November 25, 2016Research and Development, Sales and Marketing AstraZeneca, Daprodustat, GSK, GlaxoSmithKline, anaemia
GlaxoSmithKline has announced that they will begin Phase 3 development of their anaemia drug, daprodustat. The drug is an oral …
Top Ten most popular articles on Pharmafile this week
November 25, 2016Medical Communications November, news, pharmaceutical, top 10, top ten, top ten stories
This week has seen the pharmaceutical industry return to business as usual after the presidential election provided a boost to …
Insider interview: Roche discusses efficacy of CDF and NICE
November 25, 2016Medical Communications, Sales and Marketing CDF, NICE, Roche
Deborah Lancaster, Head of Market Access at Roche, discusses, in the latest issue of Pharmafile, the efficacy of the National …
Lowered price wins NICE approval for Janssen leukaemia treatment
November 25, 2016Medical Communications, Sales and Marketing Janssen, NICE, SMC, chronic lymphocytic leukaemia, ibrutinib, imbruvica
After being knocked back in the beginning of June this year, NICE has announced that Janssen’s Imbruvica (ibrutinib) will now …
Opdivo first PD-1 inhibitor given European approval for haematological cancer
November 25, 2016Medical Communications, Sales and Marketing BMS, Bristol-Myers Squibb, EMA, PD1-Inhibitor, bristol myers-squibb
Bristol-Myers Squibb announced that it has received the first and only European approval for a PD1 inhibitor in the treatment …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
